ClinicalTrials.Veeva

Menu

TCF7L2 Polymorphisms Influence on Glycemic Control in ICU Patients With Organ Failure (READIAB-G4)

U

University Hospital, Lille

Status

Completed

Conditions

Multiple Organ Failure
Hyperglycemia
Genetic Predisposition to Disease
Intensive Care Unit Syndrome

Treatments

Genetic: genetic analysis
Biological: blood and stools samples

Study type

Observational

Funder types

Other

Identifiers

NCT03055169
2010-A00997-32 (Other Identifier)
2009_58

Details and patient eligibility

About

This study evaluates the link between genetic polymorphisms as r7903146, rs12255372 of TCF7L2 gene and the risk of developing hyperglycemia during Intensive care unit stay

Enrollment

994 patients

Sex

All

Ages

18 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • admission in ICU>48h
  • at least one organ dysfunction

Exclusion criteria

  • age< 18 years
  • pregnant women
  • admission less than 48h

Trial design

994 participants in 1 patient group

intensive care patients
Description:
patients with a least one organ dysfunction
Treatment:
Biological: blood and stools samples
Genetic: genetic analysis

Trial contacts and locations

5

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems